Medigene AG Capital Reinvestment Ratio

Latest as of June 2022: 0.01x

Medigene AG capital reinvestment ratio. Medigene AG (MDG1) has a Capital Reinvestment Ratio of 0.01x as of June 2022, meaning it reinvests 0% of its operating cash flow (€17.30 Million) in capital expenditures (€230.00K). Check Medigene AG investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.01x
Capex / Operating Cash Flow

Operating Cash Flow

€17.30 Million
EUR

Capital Expenditures

€230.00K
EUR

Data as of

Jun 2022
Most recent filing

Capital Reinvestment Ratio of Medigene AG (2011–2022)

Capital reinvestment ratio of Medigene AG from 2011 to 2022. This chart tracks Medigene AG's Capital Reinvestment Ratio across 2 annual periods. Also explore Medigene AG (MDG1) equity growth momentum to track the company's year-over-year net asset growth rate.

Medigene AG Capital Reinvestment Ratio by Year (2011–2022)

Medigene AG capital reinvestment ratio by year from 2011 to 2022. For the full cash flow conversion analysis, see how efficiently does Medigene AG generate cash.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2022 0.08x €11.98 Million €1.01 Million ▲ +42.2%
2011 0.06x €6.86 Million €406.00K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow